HealthpointCapital is a values-driven, research-based private equity firm
exclusively focused on the musculoskeletal sector — specifically orthopedics and dental. HealthpointCapital manages in excess of $1 billion of institutional capital.
Orthopedic & Dental Industry Research
Most Recent Blog Articles Complete Archive »
Earnings Biomet reported net sales of $639.0 million for FQ4:09, which represents an increase of 1% as reported and 7% when adjusting for currency. Among segments, recon, excluding dental, increased 3% as reported and 11% constant currency. Dental decreased by... more
A study published in JAMA reviewed use of BMPs in spinal fusion surgeries, and outcomes included higher complication rates for off-label use in cervical fusions and increased charges for all procedures. Researchers at Brigham and Women's Hospital in Boston conducted... more
Biomet pre-announced sales results on Friday for their fourth quarter and fiscal year 2009, which ended May 31, 2009. The company reported net sales of $639.0 million for FQ4:09, which represents an increase of 1% as reported and 7% when... more
We reported back in April that teriparatide, a recombinant form of parathyroid hormone marketed by Eli Lilly as Forteo, may help bones to heal following a fracture. Now a new study published in JBJS reports on an additional application for... more
